Data search
Results for MligTC455_15826
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_15826 | 183 | 3.80 | Mlig455_041360 | Neo: - Age: - |
FYN | Mlig455_041360 {REF} {Length: 4002} {TRANSSPLICED} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=282.1]; Protein kinase domain [PF00069.27, score=154.1]; SH2 domain [PF00017.26, score=56.5]; SH3 domain [PF00018.30, score=39.5]; Variant SH3 domain [PF14604.8, score=31.3]; ABC1 atypical kinase-like domain [PF03109.18, score=23.9]; Variant SH3 domain [PF07653.19, score=20.8]} {Human: ENSG00000010810, FYN, FYN proto-oncogene, Src family tyrosine kinase, [Score=405, Expect=2e-135]; ENSG00000136573, BLK, BLK proto-oncogene, Src family tyrosine kinase, [Score=400, Expect=6e-134]; ENSG00000101336, HCK, HCK proto-oncogene, Src family tyrosine kinase, [Score=399, Expect=3e-133]; ENSG00000176105, YES1, YES proto-oncogene 1, Src family tyrosine kinase, [Score=394, Expect=9e-131]; ENSG00000197122, SRC, SRC proto-oncogene, non-receptor tyrosine kinase, [Score=393, Expect=7e-131]; ENSG00000285369, AC270286.1, BLK proto-oncogene, Src family tyrosine kinase, [Score=387, Expect=5e-130]; ENSG00000254087, LYN, LYN proto-oncogene, Src family tyrosine kinase, [Score=387, Expect=7e-129]} {Mouse: ENSMUSG00000019843, Fyn, Fyn proto-oncogene, [Score=405, Expect=2e-135]; ENSMUSG00000003283, Hck, hemopoietic cell kinase, [Score=402, Expect=1e-134]; ENSMUSG00000014932, Yes1, YES proto-oncogene 1, Src family tyrosine kinase, [Score=394, Expect=2e-131]; ENSMUSG00000014453, Blk, B lymphoid kinase, [Score=394, Expect=8e-132]; ENSMUSG00000027646, Src, Rous sarcoma oncogene, [Score=393, Expect=9e-131]; ENSMUSG00000042228, Lyn, LYN proto-oncogene, Src family tyrosine kinase, [Score=388, Expect=1e-129]; ENSMUSG00000028874, Fgr, FGR proto-oncogene, Src family tyrosine kinase, [Score=386, Expect=2e-128]} {Dmel: FBgn0264959, Src42A, Src oncogene at 42A, [Score=379, Expect=6e-126]} {Celegans: WBGene00005078, src-2, Tyrosine protein-kinase src-2, [Score=370, Expect=1e-122]} {Smed: dd_Smed_v6_3363_0_1, dd_Smed_v6_3363_0_1, [Score=508, Expect=1e-176]} {RNA1509_18489} {RNA1310_21440, RNA1509_18489} {RNA1509_18489, RNA815_20849} |
Cumulative graph for MligTC455_15826
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -5.597 | 2.489 | 0.18941 | 0.82239 | |
| RegionR2 | 0.791 | 2.489 | 0.40204 | 0.79600 | |
| RegionR3 | 0.253 | 2.489 | 0.73676 | 1.00000 | |
| RegionR4 | 1.363 | 2.489 | 0.10788 | 0.32345 | |
| RegionR5 | 0.191 | 2.489 | 0.76697 | 1.00000 | |
| RegionR6 | 0.127 | 2.489 | 0.80149 | 1.00000 | |
| RegionR7 | 1.48 | 2.489 | 0.08506 | 0.56157 | |
| RegionR8 | 1.393 | 2.489 | 0.17898 | 0.76089 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -0.191 | 2.489 | 1.00000 | 1.00000 | |
| RegenerationR2 | -0.061 | 2.489 | 0.88610 | 1.00000 | |
| RegenerationR3 | -1.215 | 2.489 | 0.04507 | 0.37085 | |
| RegenerationR4 | -1.097 | 2.489 | 0.04986 | 0.35983 | |
| RegenerationR5 | -0.327 | 2.489 | 0.52524 | 0.87214 | |
| RegenerationR6 | -2.552 | 2.489 | 0.00246 | 0.05604 | |
| RegenerationBL | -6.36 | 2.489 | 0.00044 | 0.01288 | |
| RegenerationTP | -0.944 | 2.489 | 0.19200 | 0.63032 |
Genes with expression patterns similar to MligTC455_15826
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_15826 | 183 | 3.8 | Mlig455_041360 | Neo: - Age: - |
FYN | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_041360 {REF} {Length: 4002} {TRANSSPLICED} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=282.1]; Protein kinase domain [PF00069.27, score=154.1]; SH2 domain [PF00017.26, score=56.5]; SH3 domain [PF00018.30, score=39.5]; Variant SH3 domain [PF14604.8, score=31.3]; ABC1 atypical kinase-like domain [PF03109.18, score=23.9]; Variant SH3 domain [PF07653.19, score=20.8]} {Human: ENSG00000010810, FYN, FYN proto-oncogene, Src family tyrosine kinase, [Score=405, Expect=2e-135]; ENSG00000136573, BLK, BLK proto-oncogene, Src family tyrosine kinase, [Score=400, Expect=6e-134]; ENSG00000101336, HCK, HCK proto-oncogene, Src family tyrosine kinase, [Score=399, Expect=3e-133]; ENSG00000176105, YES1, YES proto-oncogene 1, Src family tyrosine kinase, [Score=394, Expect=9e-131]; ENSG00000197122, SRC, SRC proto-oncogene, non-receptor tyrosine kinase, [Score=393, Expect=7e-131]; ENSG00000285369, AC270286.1, BLK proto-oncogene, Src family tyrosine kinase, [Score=387, Expect=5e-130]; ENSG00000254087, LYN, LYN proto-oncogene, Src family tyrosine kinase, [Score=387, Expect=7e-129]} {Mouse: ENSMUSG00000019843, Fyn, Fyn proto-oncogene, [Score=405, Expect=2e-135]; ENSMUSG00000003283, Hck, hemopoietic cell kinase, [Score=402, Expect=1e-134]; ENSMUSG00000014932, Yes1, YES proto-oncogene 1, Src family tyrosine kinase, [Score=394, Expect=2e-131]; ENSMUSG00000014453, Blk, B lymphoid kinase, [Score=394, Expect=8e-132]; ENSMUSG00000027646, Src, Rous sarcoma oncogene, [Score=393, Expect=9e-131]; ENSMUSG00000042228, Lyn, LYN proto-oncogene, Src family tyrosine kinase, [Score=388, Expect=1e-129]; ENSMUSG00000028874, Fgr, FGR proto-oncogene, Src family tyrosine kinase, [Score=386, Expect=2e-128]} {Dmel: FBgn0264959, Src42A, Src oncogene at 42A, [Score=379, Expect=6e-126]} {Celegans: WBGene00005078, src-2, Tyrosine protein-kinase src-2, [Score=370, Expect=1e-122]} {Smed: dd_Smed_v6_3363_0_1, dd_Smed_v6_3363_0_1, [Score=508, Expect=1e-176]} {RNA1509_18489} {RNA1310_21440, RNA1509_18489} {RNA1509_18489, RNA815_20849} |
| 2. | MligTC455_05325 | 71 | 1.48 | Mlig455_053845 | Neo: - Age: - Region-enriched R2: 9.011/0.00001 |
PDE1C | 1.757 | - | - | - | - | 0.976 | 0.781 | Mlig455_053845 {REF} {Length: 3417} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.5]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=92.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [RH, Score=533, Expect=2e-177]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [RH, Score=539, Expect=5e-180]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=533, Expect=2e-175]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [RH, Score=477, Expect=2e-157]} {Smed: dd_Smed_v6_11039_0_2, dd_Smed_v6_11039_0_2, [RH, Score=597, Expect=0.0]} {RNA1509_35042} {RNA1310_15340} {RNA815_34103} |
| 3. | MligTC455_22487 | 283 | 5.89 | Mlig455_001081 | Neo: - Age: - |
1.669 | 0.709 | - | - | - | - | 0.960 | Mlig455_001081 {REF} {Length: 3990} {TRANSSPLICED} {Smed: dd_Smed_v6_11081_0_2, dd_Smed_v6_11081_0_2, [Score=62.0, Expect=1e-09]} {RNA1509_12629} {RNA1310_2194.1} {RNA815_7569} | |
| 4. | MligTC455_43853 | 362 | 7.54 | Mlig455_012356, Mlig455_012734 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.748 Region-enriched R7: 4.417/0.00001 |
ARRDC2 | 0.973 | - | - | - | - | 0.973 | - | Mlig455_012356 {REF} {Length: 2499} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=66.9]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=65.2]} {Human: ENSG00000105643, ARRDC2, arrestin domain containing 2, [Score=115, Expect=7e-28]} {Mouse: ENSMUSG00000110906, Arrdc2, arrestin domain containing 2, [Score=95.9, Expect=3e-21]; ENSMUSG00000002910, Arrdc2, arrestin domain containing 2, [Score=95.9, Expect=3e-21]} {Dmel: FBgn0035103, Vdup1, Vitamin D[[3]] up-regulated protein 1, [RH, Score=116, Expect=5e-29]} {Celegans: WBGene00011732, arrd-17, Arrestin domain-containing protein 17, [Score=98.2, Expect=3e-22]} {Smed: dd_Smed_v6_8715_0_1, dd_Smed_v6_8715_0_1, [Score=195, Expect=2e-57]} {RNA1509_38119} {RNA1310_18712} {RNA815_22981} Mlig455_012734 {REF} {Length: 1701} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=66.4]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=64.6]} {Human: ENSG00000105643, ARRDC2, arrestin domain containing 2, [Score=116, Expect=2e-28]} {Mouse: ENSMUSG00000110906, Arrdc2, arrestin domain containing 2, [Score=98.2, Expect=4e-22]; ENSMUSG00000002910, Arrdc2, arrestin domain containing 2, [Score=98.2, Expect=4e-22]} {Dmel: FBgn0035103, Vdup1, Vitamin D[[3]] up-regulated protein 1, [RH, Score=114, Expect=2e-28]} {Celegans: WBGene00011732, arrd-17, Arrestin domain-containing protein 17, [Score=95.5, Expect=2e-21]} {Smed: dd_Smed_v6_8715_0_1, dd_Smed_v6_8715_0_1, [Score=194, Expect=7e-57]} {RNA1509_38119} {RNA1310_18712} {RNA815_22981} |
| 5. | MligTC455_46594 | 591 | 12.31 | Mlig455_037738 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.869/0.00006 |
0.961 | - | - | - | - | 0.961 | - | Mlig455_037738 {REF} {Length: 2043} {RNA1509_42203} {RNA1310_65422.3, RNA1509_42203} {RNA1509_42203, RNA815_30338} | |
| 6. | MligTC455_48379 | 324 | 6.74 | Mlig455_050198 | Neo: - Age: Down-Up-Down |
CCDC154 | 0.952 | - | - | - | - | - | 0.952 | Mlig455_050198 {REF} {Length: 4723} {Pfam: Coiled-coil domain-containing protein 154 [PF15450.8, score=53.6]} {Human: ENSG00000197599, CCDC154, coiled-coil domain containing 154, [Score=59.7, Expect=1e-08]} {Mouse: ENSMUSG00000059562, Ccdc154, coiled-coil domain containing 154, [Score=61.6, Expect=2e-09]} {Smed: dd_Smed_v6_10236_0_1, dd_Smed_v6_10236_0_1, [Score=311, Expect=1e-94]} {RNA1509_14849} {RNA1310_2829} {RNA815_10060} |
| 7. | MligTC455_51399 | 52 | 1.09 | Mlig455_051021 | Neo: - Age: Up-Down-Down |
KCNT1 | 0.952 | - | - | - | - | 0.952 | - | Mlig455_051021 {REF} {Length: 4250} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=92.3]; Ion channel [PF07885.18, score=44.0]} {Human: ENSG00000107147, KCNT1, potassium sodium-activated channel subfamily T member 1, [Score=901, Expect=0.0]; ENSG00000162687, KCNT2, potassium sodium-activated channel subfamily T member 2, [Score=862, Expect=0.0]} {Mouse: ENSMUSG00000058740, Kcnt1, potassium channel, subfamily T, member 1, [Score=870, Expect=0.0]; ENSMUSG00000052726, Kcnt2, potassium channel, subfamily T, member 2, [Score=870, Expect=0.0]} {Dmel: FBgn0261698, SLO2, slowpoke 2, [RH, Score=818, Expect=0.0]} {Celegans: WBGene00004831, slo-2, SLO-2 potassium channel; SLOwpoke potassium channel family, [Score=666, Expect=0.0]} {Smed: dd_Smed_v6_9739_0_1, dd_Smed_v6_9739_0_1, [Score=1093, Expect=0.0]} {RNA1509_10851} {RNA1310_10826.1} {RNA815_3987} |
| 8. | MligTC455_36768 | 627 | 13.06 | Mlig455_047617, Mlig455_047668 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.354 Region-enriched R4: 2.336/0.01334 |
CASP3 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_047617 {REF} {Length: 5415} {Pfam: Caspase domain [PF00656.24, score=97.8]} {Human: ENSG00000164305, CASP3, caspase 3, [Score=63.5, Expect=3e-10]} {Mouse: ENSMUSG00000025888, Casp1, caspase 1, [Score=67.4, Expect=2e-11]} {Dmel: FBgn0028381, Decay, Death executioner caspase related to Apopain/Yama, [Score=49.7, Expect=6e-06]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=60.8, Expect=1e-09]} {RNA1509_18240} {RNA1310_3181} {RNA815_2826} Mlig455_047668 {REF} {Length: 3971} {Pfam: Caspase domain [PF00656.24, score=97.8]} {Human: ENSG00000164305, CASP3, caspase 3, [Score=63.5, Expect=3e-10]} {Mouse: ENSMUSG00000025888, Casp1, caspase 1, [Score=67.4, Expect=2e-11]} {Dmel: FBgn0028381, Decay, Death executioner caspase related to Apopain/Yama, [Score=49.7, Expect=6e-06]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=60.8, Expect=1e-09]} {RNA1509_18240, RNA1509_55746} {RNA1310_3181, RNA1509_55746} {RNA1509_55746, RNA815_2826} |
| 9. | MligTC455_51648 | 71 | 1.49 | Mlig455_055670 | Neo: - Age: Down-Down-Up |
0.951 | - | - | - | - | - | 0.951 | Mlig455_055670 {REF} {Length: 3196} {Pfam: Integrase core domain [PF00665.28, score=19.1]; Integrase core domain [PF13683.8, score=19.0]} {Smed: dd_Smed_v6_94688_0_1, dd_Smed_v6_94688_0_1, [Score=77.4, Expect=4e-18]} {RNA1509_24311} {RNA1310_35472} {RNA815_10275} |
Berezikov Lab - 2020-2021 © ERIBA